Cobenfy could break dopamine dominance in schizophrenia treatment: GlobalData
Cobenfy is a twice-daily oral medication that combines xanomeline, a muscarinic receptor agonist, and trospium chloride, a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.